Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Pembrolizumab for Ovarian Cancer
Recruiting1 awardPhase 2
New York, New York
This trial looks at how effective pembrolizumab is in treating participants with cancer that has spread to other parts of the body. Monoclonal antibodies, like pembrolizumab, may prevent tumor cells from growing and spreading.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.